BMRA Biomerica, Inc. - Fundamental Analysis
BEARISH
Sign in to save
Save this symbol to a watchlist or track a position.
BMRA Stock | Fundamental Analysis & Investment Insights
NASDAQ
Healthcare
Medical Devices
Current Price
Live
$2.57
52W High
$8.8
52W Low
$2.11
At a glance
Key valuation, profitability, growth, and risk metrics.
AI Analysis
Powered by advanced machine learning algorithms
Confidence Score
95%
Analysis Accuracy
The Advanced Deterministic Scorecard reveals severe financial distress with a Piotroski F-Score of just 1/9, indicating extremely weak fundamental health. Despite a seemingly healthy Current Ratio of 3.25 and low Debt/Equity of 0.06, the company is plagued by deep profitability issues, including a -90.31% profit margin and -84.30% ROE. Revenue has declined by 26% year-over-year, and the stock has lost 95.7% of its value over five years, reflecting persistent operational failures and lack of investor confidence. The absence of an Altman Z-Score due to incomplete data further limits confidence in solvency assessments, but the overwhelming negative trends in earnings, margins, and price performance dominate the outlook.
Key Strengths
Low Debt/Equity ratio of 0.06 suggests minimal leverage risk
Current Ratio of 3.25 indicates strong short-term liquidity
Quick Ratio of 2.18 supports near-term financial flexibility
Forward P/E of 6.59 appears low relative to sector average of 215, suggesting potential value if turnaround occurs
Gross margin, though thin, remains positive at 5.63%
Key Risks
Piotroski F-Score of 1/9 signals critical weakness in earnings, leverage, and operating efficiency
Profit margin of -90.31% and operating margin of -113.47% reflect severe unprofitability
Revenue growth down 26% YoY, indicating shrinking top line and possible market rejection
History of massive earnings misses: average surprise of -256.34% over last 4 quarters
Stock down 95.7% over 5 years with no analyst coverage, signaling abandonment by institutional interest
Performance Snowflake
Multi-dimensional AI analysis across 5 key categories
Stock Price & Analyst Targets
Real-time price movements and analyst price targets
Historical Performance Trends
Long-term financial metrics and growth patterns
Valuation Metrics
Key valuation ratios and pricing indicators
Profitability, Growth & Financial Health
Detailed profit margins, ROE, debt ratios, and liquidity metrics
Sector Comparison & Peer Analysis
Compare BMRA against industry averages and similar companies
Insider Trading & Analyst Ratings
Track insider transactions and Wall Street analyst recommendations
Past News Coverage
Recent headlines mentioning BMRA from our newsroom.
Newest → oldest
No matching news yet.